This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Hang on a second…

This CME Activity has expired and is no longer available for credit.

Stroke Prevention in Atrial Fibrillation: Sharing Decision Making for Optimal Anticoagulation

Stroke Prevention in Atrial Fibrillation: Sharing Decision Making for Optimal Anticoagulation

Format

Webcast

Time to Complete

1 hour

Released

February 26, 2015

Expires

February 26, 2016
Add to Queue


Maximum Credits

1.00 /AMA PRA Category 1 CreditsTM

Providership Statement

This activity is jointly provided by Duke University Health System Department of Clinical Education and Professional Development and Haymarket Medical Education.

Commercial Supporter

Supported by educational grants from Boehringer Ingelheim and Daiichi Sankyo, Inc.

Program Description

Atrial fibrillation (AF) is associated with a 4- to 5-fold increase in the risk for ischemic stroke and systemic embolism, yet less than one-half of patients with AF undergo appropriate risk stratification and anticoagulant therapy. A challenge in the management of older patients with AF is balancing the need for anticoagulation to prevent stroke with the high risk of hemorrhage. This involves considering the limitations of traditional warfarin therapy and the complexities of newer anticoagulant treatments. This expert panel discussion features case examples highlighting effective clinician-patient communication about stroke prevention in AF.

Intended Audience

Intended for primary care physicians, cardiologists, physician assistants, nurse practitioners, and hospitalists who treat patients with AF

Educational Objectives

After taking part in this educational activity, participants should be better able to:

  • Recognize the large degree of underutilization of anticoagulation in patients with AF and the resultant morbidity, mortality, and health care costs
  • Outline strategies recommended in clinical guidelines to assess risk for stroke and bleeding to optimize outcomes of anticoagulation therapy
  • Evaluate the limitations, risks, challenges, and opportunities surrounding traditional and current anticoagulation therapies
  • Implement strategies to improve communication and shared decision making between clinicians and patients/caregivers about the benefits and risks of anticoagulation therapy

Faculty

Activity Medical Director
James Daubert, MD

Professor of Medicine
Director, Clinical Electrophysiology Section
Duke University Medical Center
Durham, NC


Dr. Daubert is an expert reviewer for ACRA biopharma, Boston Scientific, Gilead Sciences, and VytronUS, Inc. He serves as an advisory board member for Biosense Webster Inc. and Gilead Sciences. Dr. Daubert is principal investigator for Biosense Webster Inc., Biotronik, Boston Scientific, Gilead Sciences, Medtronic, and St. Jude. He is a speaker for Biotronik, Boston Scientific, and Medtronic. Dr. Daubert is also a consultant for CardioFocus and Orexigen Therapeutics, Inc.

CHAIRPERSON
Samuel Z. Goldhaber, MD

Senior Physician, Brigham and Women’s Hospital
Professor of Medicine, Harvard Medical School
Boston, MA

Dr. Goldhaber is a consultant for Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Inc., Eisai, EKOS Corporation, Pfizer, Portola Pharmaceuticals, and Sanofi. Dr. Goldhaber is also principal investigator for Bristol-Myers Squibb, Daiichi Sankyo, Inc., Eisai, and Orphan – EKOS.

FACULTY
Christian T. Ruff, MD, MPH

TIMI Study Group
Cardiovascular Division
Brigham and Women’s Hospital
Harvard Medical School
Boston, MA

Dr. Ruff is an advisory board member for Bayer Pharmaceuticals, Boehringer Ingelheim, Daiichi Sankyo, Inc., and Portola Pharmaceuticals.

Elaine Hylek, MD
Professor of Medicine
Resident Unit-Section of General Internal Medicine
Boston University School of Medicine
Boston, MA

Dr. Hylek is an advisory board member for Bayer Pharmaceuticals, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Inc., Janssen, and Pfizer. Dr. Hylek serves on the executive steering committee for Bristol-Myers Squibb and Ortho-McNeil. She is also on the speakers bureau for Bayer Pharmaceuticals, Boehringer Ingelheim, and Bristol-Myers Squibb.

Publishing Staff Disclosures

The following Haymarket Medical Education planning committee member, Mary Jo Krey, hereby states that she or her spouse/life partner does not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

This activity has been planned and implemented by the Duke University Health System Department of Clinical Education & Professional Development and Haymarket Medical Education for the advancement of patient care. The Duke University Health System Department of Clinical Education & Professional Development is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for the health care team.

Designation Statement

Duke University Health System Department of Clinical Education and Professional Development designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Instructions

To obtain credit, a score of 80% or better is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the posttest survey, and have received your digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/Exam History, which you can then access at any time.

If you have any questions relating to the accreditation of this activity, please contact Duke CME at 919-401-1200.

Privacy Policy

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue